Health Canada recalls semaglutide drugs made by compounding pharmacy
Health Canada is recalling compounded drugs containing semaglutide, which is a key component in popular medications like ...
Ontario health-care CEO let go after palliative care supply shortages
A senior government source confirmed the CEO was removed from her role after the agency found itself unable to fulfil orders ...
A 'smoke-free generation' in Canada? New analysis says it would result in vast health gains, health care cost savings
Smoking stubbornly remains a leading cause of disease, disability and death in Canada, even as prevalence rates have fallen ...
JD Supra1d
Health Canada Consultation on Proposed Amendments to Address Drug and Medical Device Shortages in Canada
Health Canada is proposing to amend the Food and Drug Regulations, C.R.C., c.870 (the FDRs) and the Medical Device Regulations, SOR/98-282 (the ...
EQS-News: Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara®
Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi ® approved by Health Canada for both subcutaneous and intravenous ...